Shares Held by Insiders

Fully Diluted Shares Held by Insiders

Date

Name

Buy/Sell

$ Value

# Shares

Avg. Price

Title

President & CBO

Chief Scientific Officer

Chief Executive Officer

Chief Medical Officer

Fusion Pharmaceuticals Inc., a clinical-stage oncology company, focuses on developing radiopharmaceuticals as precision medicines in Canada and the United States. Its lead product candidates include FPI-2265 that is in Phase 2 clinical trial to treat prostate-specific membrane antigens; and FPI-1434 that is in Phase 1 clinical trial as a monotherapy in patients with solid tumors expressing insulin-like growth factor 1 receptor. The company also conducting additional preclinical studies of FPI-1434 in combination with approved checkpoint inhibitors and DNA damage response inhibitors to further assess the anti-tumor activity, and dosing schedule and pharmacodynamics of the combinations. In addition, it develops FPI-1966 for the treatment of multiple cancers, including colorectal, ovarian, bladder, and head and neck cancers. The company has a strategic collaboration agreement with AstraZeneca UK Limited to discover, develop, and commercialize alpha-emitting radiopharmaceuticals and combination therapies for the treatment of cancer. Fusion Pharmaceuticals Inc. was incorporated in 2014 and is headquartered in Hamilton, Canada.

Fusion Pharmaceuticals Inc., a clinical-stage oncology company, focuses on developing radiopharmaceuticals as precision medicines in Canad...

Datesorted ascending	Name	Buy/Sell	$ Value	# Shares	Avg. Price	Title
2023-08-31	Premium	acquired	Premium	Premium	Premium	President & CBO
2023-08-31	Premium	acquired	Premium	Premium	Premium	Chief Scientific Officer
2022-11-11	Premium	acquired	Premium	Premium	Premium	-
2022-08-11	Premium	bought	Premium	Premium	Premium	-
2022-04-27	Premium	sold	Premium	Premium	Premium	Chief Executive Officer
2022-04-26	Premium	sold	Premium	Premium	Premium	Chief Executive Officer
2022-04-25	Premium	sold	Premium	Premium	Premium	Chief Executive Officer
2022-04-21	Premium	sold	Premium	Premium	Premium	Chief Executive Officer
2022-04-20	Premium	sold	Premium	Premium	Premium	Chief Executive Officer
2022-04-13	Premium	sold	Premium	Premium	Premium	Chief Executive Officer
2022-04-12	Premium	sold	Premium	Premium	Premium	Chief Executive Officer
2022-04-11	Premium	sold	Premium	Premium	Premium	Chief Executive Officer
2022-04-08	Premium	sold	Premium	Premium	Premium	Chief Executive Officer
2022-04-07	Premium	sold	Premium	Premium	Premium	Chief Executive Officer
2022-04-06	Premium	sold	Premium	Premium	Premium	Chief Executive Officer
2022-04-05	Premium	sold	Premium	Premium	Premium	Chief Executive Officer
2022-04-04	Premium	sold	Premium	Premium	Premium	Chief Executive Officer
2022-04-01	Premium	sold	Premium	Premium	Premium	Chief Executive Officer
2022-03-30	Premium	sold	Premium	Premium	Premium	Chief Executive Officer
2022-03-29	Premium	sold	Premium	Premium	Premium	Chief Executive Officer
2022-03-28	Premium	sold	Premium	Premium	Premium	Chief Executive Officer
2022-03-25	Premium	sold	Premium	Premium	Premium	Chief Executive Officer
2022-03-23	Premium	sold	Premium	Premium	Premium	Chief Executive Officer
2022-03-22	Premium	sold	Premium	Premium	Premium	Chief Executive Officer
2022-03-21	Premium	sold	Premium	Premium	Premium	Chief Executive Officer

FUSN - Fusion Pharmaceuticals Inc Stock Price, Fair Value and News

Latest Insider Trading transactions for FUSN